T cell engaging bispecific antibodies targeting CD33 IgV and IgC domains for the treatment of acute myeloid leukemia

MLA

Madelyn Espinosa-Cotton, et al. “T Cell Engaging Bispecific Antibodies Targeting CD33 IgV and IgC Domains for the Treatment of Acute Myeloid Leukemia.” Journal for ImmunoTherapy of Cancer, vol. 9, no. 5, May 2021. EBSCOhost, https://doi.org/10.1136/jitc-2021-002509.

APA

Madelyn Espinosa-Cotton, Sayed Shahabuddin Hoseini, Hong-fen Guo, Nai-Kong V Cheung, Yi Feng, Mallika Vadlamudi, Hoa Tran, & Irene Cheung. (2021). T cell engaging bispecific antibodies targeting CD33 IgV and IgC domains for the treatment of acute myeloid leukemia. Journal for ImmunoTherapy of Cancer, 9(5). https://doi.org/10.1136/jitc-2021-002509

Chicago

Madelyn Espinosa-Cotton, Sayed Shahabuddin Hoseini, Hong-fen Guo, Nai-Kong V Cheung, Yi Feng, Mallika Vadlamudi, Hoa Tran, and Irene Cheung. 2021. “T Cell Engaging Bispecific Antibodies Targeting CD33 IgV and IgC Domains for the Treatment of Acute Myeloid Leukemia.” Journal for ImmunoTherapy of Cancer 9 (5). doi:10.1136/jitc-2021-002509.